About Beta-citrylglutamate synthase B
Beta-citrylglutamate synthase B (RIMKLB) is a protein
from Homo sapiens identified by UniProt accession
Q9ULI2, 386 residues long.
MolForge cross-references it against 0 known binders and
142 disease associations.
Target properties
| Protein name | Beta-citrylglutamate synthase B |
| UniProt accession | Q9ULI2 |
| Gene | RIMKLB |
| Organism | Homo sapiens |
| Length | 386 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (142)
Diseases linked to this target (Open Targets).
- reticulocyte count · score 0.41
- mean platelet volume · score 0.40
- Calcium channel blocker use measurement · score 0.37
- platelet count · score 0.36
- reticulocyte measurement · score 0.36
- hypertension · score 0.34
- Immature Reticulocyte Fraction Measurement · score 0.34
- lymphocyte count · score 0.33
- diastolic blood pressure · score 0.32
- neurodegenerative disease · score 0.31
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9ULI2-F1 | alphafold | PREDICTED | 80.64 | — |
Amino-acid sequence (386 residues)
MCSSVAAKLW FLTDRRIRED YPQKEILRAL KAKCCEEELD FRAVVMDEVV LTIEQGNLGL RINGELITAY PQVVVVRVPT PWVQSDSDIT VLRHLEKMGC RLMNRPQAIL NCVNKFWTFQ ELAGHGVPLP DTFSYGGHEN FAKMIDEAEV LEFPMVVKNT RGHRGKAVFL ARDKHHLADL SHLIRHEAPY LFQKYVKESH GRDVRVIVVG GRVVGTMLRC STDGRMQSNC SLGGVGMMCS LSEQGKQLAI QVSNILGMDV CGIDLLMKDD GSFCVCEANA NVGFIAFDKA CNLDVAGIIA DYAASLLPSG RLTRRMSLLS VVSTASETSE PELGPPASTA VDNMSASSSS VDSDPESTER ELLTKLPGGL FNMNQLLANE IKLLVD
Explore Beta-citrylglutamate synthase B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets